Protalix BioTherapeutics Stock (AMEX: PLX) stock price, news, charts, stock research, profile.
Open | $1.160 |
Close | $1.200 |
Volume / Avg. | 272.095K / 351.093K |
Day Range | 1.160 - 1.240 |
52 Wk Range | 1.090 - 3.550 |
Market Cap | $87.663M |
P/E Ratio | 13.111 |
Dividend Yield | - |
Exchange | AMEX |
RSI | 46 |
Short Interest | 9.08% |
Days to Cover | 15.59 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Protalix BioTherapeutics (AMEX: PLX) through any online brokerage.
Other companies in Protalix BioTherapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), Curis (NASDAQ:CRIS), CARISMA Therapeutics (NASDAQ:CARM), Connect Biopharma Hldgs (NASDAQ:CNTB) and Burning Rock Biotech (NASDAQ:BNR).
The latest price target for Protalix BioTherapeutics (AMEX: PLX) was reported by HC Wainwright & Co. on Tuesday, November 14, 2023. The analyst firm set a price target for 10.00 expecting PLX to rise to within 12 months (a possible 800.90% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Protalix BioTherapeutics (AMEX: PLX) is $1.11 last updated April 23, 2024 at 12:26 AM EDT.
There are no upcoming dividends for Protalix BioTherapeutics.
Protalix BioTherapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Protalix BioTherapeutics.
Protalix BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.